Printer-Friendly      

Feasibility and Sensitivity of a Symptom Monitoring Application in Real Time (SMART) for ALS

Study Purpose:

The purpose of this study is to determine if a smartphone application would be helpful in collecting research data to better inform us about ALS disease progression. This study asks each participant to use a smartphone application for a few minutes each week to answer a questionnaire and complete a voice recording. This is a pilot study in which a smartphone application was designed and customized for use in ALS clinical trials.

Disease:

Amyotrophic Lateral Sclerosis (ALS),  Familial ALS,  Sporadic ALS

Study Type:

Observational Study

Study Category:

Study Status:

Enrolling

Phase:

Not Applicable

Study Chair(s)/Principal Investigator(s):

James Berry, MD, MPH, Massachusetts General Hospital

Clinicaltrials.gov ID (11 digit #):

Not Applicable

Neals Affiliated?

No

Coordinating Center Contact Information

Massachusetts General Hospital
Ella Collins / .(JavaScript must be enabled to view this email address)
Minhaj Rahman / .(JavaScript must be enabled to view this email address) / 617-726-1880
55 Fruit Street
Boston, Massachusetts 02114 United States

Full Study Summary:

Massachusetts General Hospital is seeking individuals to participate in a research study enrolling under the direction of James Berry, MD, MPH. The study is funded by Philanthropy, a NIH Grant, and the Neurological Clinical Research Institute. This study is recruiting adults with Amyotrophic Lateral Sclerosis (ALS) who are smartphone users and are able to download and use a smartphone application. Participants should know that these visits can coincide with their routine clinic visits.

Study Sponsor:

Philanthropy, NIH Grant, and the Neurological Clinical Research Institute

Participant Duration:

1 year

Estimated Enrollment:

Estimated Study Start Date:

07/20/2016

Estimated Study Completion Date:

Posting Last Modified Date:

02/25/2020

Date Study Added to alsconsortium.org:

12/08/2016
  • More Information

    For more information, visit https://clinicaltrials.partners.org/study/9989

  • Eligibility Criteria

    Gender:

    Female, Male

    Minimum Age:

    18

    Maximum Age:

    N/A

    Time since Symptom Onset:

    N/A

    Time since Diagnosis:

    N/A

    Can participants use Riluzole?

    Yes


    The study is currently recruiting participants who meet the following guideline:

    Adults with Amyotrophic Lateral Sclerosis (ALS) and ability to download and use the smartphone application on their smartphone device (iPhone or Android).

  • Site Contact Information

    Massachusetts General Hospital
    Ella Collins / .(JavaScript must be enabled to view this email address) / Minhaj Rahman / .(JavaScript must be enabled to view this email address) / 617-726-1880
    55 Fruit Street
    Boston, Massachusetts 02114
    United States